Idera Pharmaceuticals, Inc. (IDRA) Reports Q1 EPS Loss of $0.25
Tweet Send to a Friend
Idera Pharmaceuticals, Inc. (NASDAQ: IDRA) reported Q1 ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
